Elevance Health Inc (ELV) reports robust financial performance with a focus on strategic growth and shareholder returns, ...

Elevance Health (NYSE: ELV) Q4 2024 Earnings Call Jan 23, 2025, 8:30 a.m. ET ...

Financial writer recommends buying Elevance Health stock despite recent drop, citing strong industry trends and potential for ...

Elevance Health Inc. (ELV), while reporting weak fourth-quarter earnings below market estimates, on Thursday issued fiscal 2025 ...

Elevance Health posted $418 million in profit for the fourth quarter of 2024, a figure that surpassed Wall Street's ...

Elevance Health Q4 revenues hit $45 billion, driven by premium growth and acquisitions. 2025 EPS guidance is $34.15-$34.85, with a $1.71 dividend declared.

Centene (CNC) and Molina Healthcare (MOH) were among the notable gainers in the premarket on Thursday after their rival in the Medicaid space, Elevance Health (NYSE:ELV), reported better-than-expected ...

Major healthcare plan provider UnitedHealth Group Incorporated UNH reported strong fourth-quarter earnings last week, primarily driven by growth in domestic commercial membership and Medicare ...

Mizuho Securities analyst Ann Hynes has maintained their bullish stance on ELV stock, giving a Buy rating on January 16.Invest with ...

Elevance Health reported stronger-than-expected results and raised its dividend as it benefited from higher premiums, acquisitions, and growth in its pharmacy division.

Elevance Health released fourth-quarter earnings that topped analyst expectations, sending its stock higher in pre-market ...

Mark Kaye, the chief financial officer, said the company took a "very disciplined approach between competitiveness and underwriting." ...